INSIDER · CIK 1898644
Cohen Joshua B
Co-Chief Executive Officer, Director at Amylyx Pharmaceuticals, Inc. (AMLX)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$981KSold on the market
1Companies
Sep 14, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 202616:00 | Sep 10, 2026 | AMLXAmylyx Pharmaceuticals, Inc. | Co-Chief Executive Officer, Director | S · Sell | $32.19 | −30,464 | 3,613,123 | -1% | −$981K | ||
| Aug 20, 202621:00 | Aug 18, 2026 | AMLXAmylyx Pharmaceuticals, Inc. | Co-Chief Executive Officer, Director | A · Grant | — | +60,039 | 3,643,587 | +2% | — |